Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
January 21, 2020
Patent Application Number
15449665
Date Filed
March 3, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention provides monoclonal antibodies that specifically bind to TIGIT. The monoclonal antibodies have the capacity for substantial activation of T cells and natural killer cells by inhibiting binding of TIGIT to CD155. The monoclonal antibodies can be used for treatment of cancer and infectious disease, among other applications.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
